Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage 2 Hypertension”

304 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 304 results

Post-approval studies (Phase 4)Study completedNCT00185068
What this trial is testing

An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension

Who this might be right for
Hypertension
Daiichi Sankyo 110
Testing effectiveness (Phase 2)Study completedNCT01915940
What this trial is testing

Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension

Who this might be right for
Primary Open-Angle GlaucomaOcular Hypertension
ForSight Vision5, Inc. 169
Post-approval studies (Phase 4)Study completedNCT00931710
What this trial is testing

Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension

Who this might be right for
Stage 2 Systolic Hypertension
Novartis 488
Large-scale testing (Phase 3)Study completedNCT03868124
What this trial is testing

Clinical Study Comparing Two Models of a Travoprost Intraocular Implant

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Glaukos Corporation 560
Testing effectiveness (Phase 2)Ended earlyNCT04053543
What this trial is testing

CXA-10 Study in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
PAH
Complexa, Inc. 33
Early research (Phase 1)Study completedNCT06008015
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers

Who this might be right for
Hypertension
Boryung Pharmaceutical Co., Ltd 44
Not applicableStudy completedNCT00794170
What this trial is testing

Interactive Study to Increase Glaucoma Adherence to Treatment

Who this might be right for
Glaucoma
Emory University 312
Testing effectiveness (Phase 2)Study completedNCT00423592
What this trial is testing

Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Hypertension
Gilead Sciences 36
Post-approval studies (Phase 4)Study completedNCT01057251
What this trial is testing

Nebivolol in Patients With Systolic Stage 2 Hypertension

Who this might be right for
Hypertension
Forest Laboratories 433
Testing effectiveness (Phase 2)Study completedNCT02017444
What this trial is testing

Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.

Who this might be right for
Idiopathic Intracranial Hypertension
University of Birmingham 31
Testing effectiveness (Phase 2)Study completedNCT02014142
What this trial is testing

Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma

Who this might be right for
Ocular HypertensionOpen-Angle Glaucoma
Mati Therapeutics Inc. 86
Large-scale testing (Phase 3)Looking for participantsNCT07064473
What this trial is testing

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Who this might be right for
Diabetes Mellitus, Type 2HypertensionCardiovascular Diseases
Boehringer Ingelheim 11,800
Early research (Phase 1)Study completedNCT06744439
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 49
Testing effectiveness (Phase 2)Ended earlyNCT01725256
What this trial is testing

Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 29
Testing effectiveness (Phase 2)Study completedNCT02822222
What this trial is testing

Safety Study of RMJH-111b to Treat Essential Hypertension

Who this might be right for
Essential Hypertension
RMJ Holdings, LLC 22
Not applicableUnknownNCT02060981
What this trial is testing

Evaluation of a Decision Support Tool

Who this might be right for
Medication AdherenceHypertensionDecision Making, Shared+1 more
Brigham and Women's Hospital 140
Testing effectiveness (Phase 2)Study completedNCT05001945
What this trial is testing

Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension

Who this might be right for
Hypertension, Renal
Mineralys Therapeutics Inc. 200
Testing effectiveness (Phase 2)Study completedNCT02234141
What this trial is testing

Selonsertib in Adults With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Gilead Sciences 151
Testing effectiveness (Phase 2)Looking for participantsNCT05587712
What this trial is testing

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

Who this might be right for
Pulmonary Arterial Hypertension
Merck Sharp & Dohme LLC 42
Not applicableWithdrawnNCT01260857
What this trial is testing

Safety And Efficacy Of Spirinolactone Plus Hydroflumethiazide In The Treatment Of Filipino Patients With Hypertension

Who this might be right for
Hypertension
Pfizer
Load More Results